10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-055043`
Period End Date	20210930
Filing Date	20211108
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	tyme-10q_20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 67 Cash Flow Statement 48 Stockholders Equity 31

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$107.52M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$46.29M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$987.47K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$560.10K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.31M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.15M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$77.38M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$109.66M	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$530.99K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$57.40K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$75.47K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$20.37M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$110.26M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$97.81M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	172.20M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	172.21M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time
Accounts payable and other current liabilities (including $68,000 and $87,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.34M	USD	Point-in-time
Accounts payable and other current liabilities (including $68,000 and $87,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.84M	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$726.03K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$653.29K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$741.20K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$38.88K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$34.66K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.64M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.77M	USD	Point-in-time
Severance payable, net of current portion	`SeverancePayableNoncurrent`	$850.71K	USD	Point-in-time
Severance payable, net of current portion	`SeverancePayableNoncurrent`	$642.96K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$19.27K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$41.26K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$1.93M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$862.61K	USD	Point-in-time
Total liabilities	`Liabilities`	$8.47M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.30M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at September 30, 2021, 300,000,000 authorized, 172,200,644 issued and outstanding at March 31, 2021	`CommonStockValue`	$17.22K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at September 30, 2021, 300,000,000 authorized, 172,200,644 issued and outstanding at March 31, 2021	`CommonStockValue`	$17.22K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$238.57M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$239.84M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-58.56K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-136.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-148.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$101.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$96.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.03M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$91.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$110.26M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$97.81M	USD	Point-in-time

Income Statement 67 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$341.00K	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$266.00K	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$151.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$138.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$7.68M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.42M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.50M	USD	1 Quarter
General and administrative (including $151,000, $138,000, $266,000 and $341,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.61M	USD	1 Quarter
General and administrative (including $151,000, $138,000, $266,000 and $341,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.43M	USD	1 Quarter
General and administrative (including $151,000, $138,000, $266,000 and $341,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$4.90M	USD	2 Qtrs
General and administrative (including $151,000, $138,000, $266,000 and $341,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$5.67M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$7.32M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$15.09M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$5.93M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$12.58M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-15.09M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-7.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-12.58M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.93M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.07M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-344.17K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-489.57K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$2.77M	USD	2 Qtrs
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$39.01K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$58.53K	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$17.51K	USD	2 Qtrs
Other income	`OtherNonoperatingIncome`	$7.01K	USD	1 Quarter
Interest expense	`InterestExpense`	$40.63K	USD	2 Qtrs
Interest expense	`InterestExpense`	$55.36K	USD	2 Qtrs
Interest expense	`InterestExpense`	$25.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$19.37K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$1.09M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-582.85K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$363.81K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$470.60K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.49M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	128.05M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	172.21M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	172.21M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	126.32M	shares	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.49M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Unrealized loss on marketable securities, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-24.71K	USD	1 Quarter
Unrealized loss on marketable securities, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-58.56K	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.59M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-11.55M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-15.68M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.85M	USD	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-11.49M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-15.68M	USD	2 Qtrs
Depreciation	`Depreciation`	$2.59K	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$1.26M	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$1.95M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.07M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-344.17K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-489.57K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$2.77M	USD	2 Qtrs
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	2 Qtrs
Net amortization of premiums and discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-722.49K	USD	2 Qtrs
Gain on call redemption of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$109.00	USD	2 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$535.38K	USD	2 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-958.36K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-425.14K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-500.30K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-132.97K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-18.07K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.55M	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-503.26K	USD	2 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-280.48K	USD	2 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-183.91K	USD	2 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.02M	USD	2 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-299.51K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-34.83K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-17.76K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.76M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.28M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$74.52M	USD	2 Qtrs
Proceeds from maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.49M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-68.03M	USD	2 Qtrs
Insurance note payments	`InsuranceNotePayments`	$343.37K	USD	2 Qtrs
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$5.81M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$6.19K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.19K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.46M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.30M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-78.30M	USD	2 Qtrs
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.22M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.40M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.22M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.40M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Interest	`InterestPaidNet`	$55.36K	USD	2 Qtrs
Interest	`InterestPaidNet`	$40.63K	USD	2 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$96.48M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$91.51M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time
Proceeds from the exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.19K	USD	1 Quarter
Proceeds from the exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	6,250.00	shares	2 Qtrs
Warrant to share exchange	`StockIssuedDuringPeriodValueWarrantToShareExchange`	$3.39M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$643.66K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$883.93K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$616.23K	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.07M	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-33.84K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.71K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.49M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$96.48M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$14.50M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$91.51M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.